Videos / Protein based COVID-19 vaccine
In this Product Explainer, Infectious Disease Physician and Clinical Microbiologist A/Prof Paul Griffin explains the recombinant protein nanoparticle COVID-19 vaccine with a proprietary adjuvant, including the mechanism of action, efficacy, and tolerability; and provides an update on boosters, indications, and access
(8 mins).
Detection, Assessment and Management of Pulmonary Fibrosis
Practical Melanoma Management for GPs
Preventing Renal Failure in Type 2 Diabetes – New Options
Management of Post-Vaccination Reactions
expert
Infectious Diseases Physician and Clinical Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland